Antimicrobial Photodynamic Activity of the Zn(II) Phthalocyanine RLP068/Cl Versus Antimicrobial-Resistant Priority Pathogens
International Journal of Molecular Sciences · 05.08.2025 · 26 (15) · 7545
DOI: 10.3390/ijms26157545 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.08.2025. Verfasst von Ilaria Baccani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine (DMSC), University of Florence, Largo Brambilla, 3, 50134 Florence, FI, Italy. Hauptthemen laut MEDLINE: Photosensitizing Agents, Indoles, Organometallic Compounds, Anti-Infective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Molteni Therapeutics, Molteni Therapeutics SRL.
Abstract (Originalsprache)
The emergence and spread of antimicrobial resistance among pathogens are significantly reducing available therapeutic options, highlighting the urgent need for novel and complementary treatment strategies. Antimicrobial photodynamic therapy (aPDT) is a promising alternative approach that can overcome antimicrobial resistance through a multitarget mechanism of action, exerting direct bactericidal and fungicidal effects with minimal risk of resistance development. Although aPDT has shown efficacy against a variety of pathogens, data on its activity against large collections of clinical multidrug-resistant strains are still limited. In this study, we assessed the antimicrobial activity of the photosensitizer RLP068/Cl combined with a red light-emitting LED source at 630 nm (Molteni Farmaceutici, Italy) against a large panel of Gram-negative and Gram-positive bacterial strains harboring relevant resistance traits and Candida species. Our results demonstrated the significant microbicidal activity of RLP068/Cl against all of the tested strains regardless of their resistance phenotype, with particularly prominent activity against Gram-positive bacteria (range of bactericidal concentrations 0.05–0.1 µM), which required significantly lower exposure to photosensitizer compared to Candida and Gram-negative species (range 5–20 µM). Overall, these findings support the potential use of RLP068/Cl-mediated aPDT as an effective therapeutic strategy for the management of localized infections caused by MDR organisms, particularly when conventional therapeutic options are limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Medicine (DMSC), University of Florence, Largo Brambilla, 3, 50134 Florence, FI, Italy.
- Microbiology and Virology Unit, Careggi University Hospital, Largo Brambilla, 3, 50134 Florence, FI, Italy.
- L. Molteni & C. dei Fratelli Alitti, Società di esercizio S.P.A. SS57 Loc. granatieri, 50018 Scandicci, FI, Italy.
ORCID-Profile: Gian Maria Rossolini
Förderung
- Molteni Therapeutics
- Molteni Therapeutics SRL
Zitieren
APA
Baccani, I., Cuffari, S., Giuliani, F., Rossolini, G. M., & Pollini, S. (2025). Antimicrobial Photodynamic Activity of the Zn(II) Phthalocyanine RLP068/Cl Versus Antimicrobial-Resistant Priority Pathogens. International Journal of Molecular Sciences, 26(15), 7545. https://doi.org/10.3390/ijms26157545
Vancouver
Baccani I, Cuffari S, Giuliani F, Rossolini GM, Pollini S. Antimicrobial Photodynamic Activity of the Zn(II) Phthalocyanine RLP068/Cl Versus Antimicrobial-Resistant Priority Pathogens. International Journal of Molecular Sciences. 2025;26(15):7545. doi:10.3390/ijms26157545
BibTeX
@article{Baccani2025,
author = {Baccani, Ilaria and Cuffari, Sara and Giuliani, Francesco and Rossolini, Gian Maria and Pollini, Simona},
title = {Antimicrobial Photodynamic Activity of the Zn(II) Phthalocyanine RLP068/Cl Versus Antimicrobial-Resistant Priority Pathogens},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {15},
pages = {7545},
doi = {10.3390/ijms26157545}
}
EUVIMED